SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue slipped marginally during the March 2026 quarter. A decline of about Rs. 15803.00 millions was observed as compared to Rs. 16500.10 millions during the corresponding quarter last year.Net profit declined -23.86% to Rs. 1917.90 millions from Rs. 2519.00 millions.The company reported a degrowth in operating Profit to 3884.50 millions from 4669.90 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 15803.00 16500.10 -4.22 60890.70 52169.80 16.72 60890.70 52169.80 16.72
Other Income 130.90 721.60 -81.86 774.30 1004.70 -22.93 774.30 1004.70 -22.93
PBIDT 3884.50 4669.90 -16.82 15156.90 10448.00 45.07 15156.90 10448.00 45.07
Interest 339.10 486.00 -30.23 1429.60 1822.00 -21.54 1429.60 1822.00 -21.54
PBDT 3545.40 4183.90 -15.26 13727.30 8626.00 59.14 13727.30 8626.00 59.14
Depreciation 951.70 881.90 7.91 3786.40 3587.90 5.53 3786.40 3587.90 5.53
PBT 2593.70 3302.00 -21.45 9940.90 5038.10 97.31 9940.90 5038.10 97.31
TAX 675.80 783.00 -13.69 2536.10 1234.20 105.49 2536.10 1234.20 105.49
Deferred Tax -9.20 -37.70 -75.60 -315.10 -304.20 3.58 -315.10 -304.20 3.58
PAT 1917.90 2519.00 -23.86 7404.80 3803.90 94.66 7404.80 3803.90 94.66
Equity 1079.70 1078.50 0.11 1079.70 1078.50 0.11 1079.70 1078.50 0.11
PBIDTM(%) 24.58 28.30 -13.15 24.89 20.03 24.29 24.89 20.03 24.29

Laurus Labs Share Price

1099.10 -6.60 (-0.60%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.20
Dr. Reddys Lab 1322.95
Cipla 1309.90
Zydus Lifesciences 891.65
Lupin 2303.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×